Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial CTSUNSABPBREB-47-M

Title

A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer 

Principal Investigator(s)

John Murray

Details

  • Protocol No. CTSUNSABPBREB-47-M
  • Open Date: 04/26/2012
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites: Breast
  • Therapies: Chemotherapy - cytotoxic; Molecular Targeted Agents / Immunotherapy / Biologics
  • Drugs: None Specified
  • Participating Institutions: Meharry Medical College
  • Secondary Protocol No: B-47

Description

None Provided.

Eligibility

Not provided. Please call for more information.